ML20033F731
| ML20033F731 | |
| Person / Time | |
|---|---|
| Issue date: | 03/16/1990 |
| From: | Glenn J NRC OFFICE OF NUCLEAR MATERIAL SAFETY & SAFEGUARDS (NMSS) |
| To: | Michnich M AMERICAN COLLEGE OF CARDIOLOGY |
| Shared Package | |
| ML20033F732 | List: |
| References | |
| NUDOCS 9003280258 | |
| Download: ML20033F731 (1) | |
Text
r-i s
nu 1.,,,,
American College of Cardfelogy i
ATTN: Marie E. Michnich, Dr.P.H.
Associate Executive Vice President l
Heart House 9111 Old soorgetown Road Sethesda, Maryland 20014 t
Dear Dr. Michnich:
In your letter of February 23,1990 you requested clarification of Nuclear Regulatory Cosmission (MRC) regulations regarding the interpretation of radionuclide studies.
The NRC s regulations concerning sedical use are setforthin10CFRPart35fenclosed).
Medical use is defined in 10 CFR 35.2 as "the intentional internal or external administration of byproduct material or the radiation therefres to husen beings in.the practice of medicine..,.." The definition of medical t use and the requirements of 10 CFR Part 35 do not extend to the interpretation of radionuclide studies: that is considered to be within the practice of e
medicine and outside the scope of MRC regulation. The NRC does not regulate 4
j matters of compensation.
If you have any questions, please contact me or members of my staff at
(
(301)492-3418.
Sincerely, ernstant signed P7*
John E. Glenn, Chief Medical, Academic, and Commercial Use Safety Branch Division of Industrial and
,q Medical Nuclear Safety, NM$$
t.,
s Enclosures,'4s stated u
)
1
_. _ _ _ _ _ _ _. _ _ _ _ -.. _ _. _. -.. _,. _ _ _ _